• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[T1N0期乳腺癌术前放疗的组织学及生物学评估]

[Histological and biological evaluation of preoperative radiotherapy on T1N0 breast carcinoma].

作者信息

Fukutomi T, Yamamoto H, Nanasawa T, Tsukiyama I, Ogino H, Itabashi M, Hirota T

机构信息

Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Nihon Geka Gakkai Zasshi. 1992 Feb;93(2):183-8.

PMID:1348103
Abstract

In order to clarify the role of radiotherapy in breast preserving surgery for early breast cancer, histological and biological effects of preoperative radiation were evaluated. Thirty-five T1N0 patients were treated by preoperative radiotherapy with beta-tron, cumulative doses of which were ranging from 25 Gy (5 Gy x 5) to 40 Gy (8 Gy x 5) and underwent subsequent modified radical mastectomy 2 or 3 weeks after the termination of radiotherapy. Clinical tumor shrinkage more than 50% was observed in 25 out of 35 cases (71%) but did not directly correlate with histological effects. Radiotherapy was basically ineffective within 25-30 Gy, whereas histological effects more than Grade 2 were gained in 8 out of 25 patients (32%), who had received 40 Gy or more. In the preoperative radiation group, there were more ER(+), PgR(+) and histologically well-differentiated cases than in the non-radiated stage I patients. Mitotic figures were also significantly reduced after radiotherapy, whereas the expression of c-erB-2 protein was unchanged between these two groups. Our data indicate the various radiosensitivity of breast cancer cells and the indication of hormone therapy for the conservative treatment of breast carcinoma.

摘要

为了阐明放射治疗在早期乳腺癌保乳手术中的作用,对术前放疗的组织学和生物学效应进行了评估。35例T1N0患者接受了使用β射线加速器的术前放疗,累积剂量为25 Gy(5 Gy×5)至40 Gy(8 Gy×5),并在放疗结束后2或3周接受了改良根治性乳房切除术。35例中有25例(71%)观察到临床肿瘤缩小超过50%,但与组织学效应无直接关联。放疗在25 - 30 Gy范围内基本无效,而在接受40 Gy或更高剂量的25例患者中有8例(32%)获得了2级以上的组织学效应。术前放疗组中ER(+)、PgR(+)和组织学高分化病例比未接受放疗的Ⅰ期患者更多。放疗后有丝分裂象也显著减少,而两组之间c-erB-2蛋白的表达没有变化。我们的数据表明乳腺癌细胞具有不同的放射敏感性以及激素治疗在乳腺癌保守治疗中的指征。

相似文献

1
[Histological and biological evaluation of preoperative radiotherapy on T1N0 breast carcinoma].[T1N0期乳腺癌术前放疗的组织学及生物学评估]
Nihon Geka Gakkai Zasshi. 1992 Feb;93(2):183-8.
2
[Problems of breast conservation therapy--residual cancers after lumpectomy and effects of preoperative radiotherapy].[保乳治疗的问题——乳房肿瘤切除术后的残留癌及术前放疗的效果]
Gan To Kagaku Ryoho. 1994 Jun;21 Suppl 2:212-6.
3
Remission rates in breast cancer treated with preoperative chemotherapy and radiotherapy.术前化疗和放疗治疗乳腺癌的缓解率。
Strahlenther Onkol. 2003 May;179(5):306-11. doi: 10.1007/s00066-003-1019-y.
4
Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.乳腺癌患者临床、病理状态、激素受体与C-erbB-2癌蛋白的相关性
Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:600-6.
5
[Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].[乳房原位导管癌的手术与放疗联合治疗:匈牙利多中心前瞻性随机研究的初步结果]
Magy Onkol. 2008 Sep;52(3):269-77. doi: 10.1556/MOnkol.52.2008.3.4.
6
Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.通过配体结合试验评估雌激素受体状态在接受保乳手术和放射治疗的早期乳腺癌患者中的预测价值。
Oncol Rep. 2002 Mar-Apr;9(2):375-8.
7
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.采用表柔比星、顺铂和持续输注氟尿嘧啶对局部晚期三阴性(激素受体阴性且人表皮生长因子受体2阴性)乳腺癌进行个体化术前治疗,随后每周给予紫杉醇。
Cancer Chemother Pharmacol. 2008 Sep;62(4):667-72. doi: 10.1007/s00280-007-0652-z. Epub 2007 Dec 7.
8
Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.乳腺导管癌中雌激素受体、孕激素受体及c-erbB2癌基因蛋白表达的改变
Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.
9
[Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma].[早期乳腺癌乳头乳晕复合体隐匿性受累的临床病理分析]
Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):203-6.
10
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.在接受多柔比星和环磷酰胺序贯紫杉醇辅助化疗的III期乳腺癌患者中,bcl-2表达的预后意义
BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63.

引用本文的文献

1
Higher Level of P-glycoprotein Expression in Human Breast Cancer Cells after Radiation Therapy.
Breast Cancer. 1995 Oct 31;2(2):99-103. doi: 10.1007/BF02966947.
2
Prognostic factors for local recurrence in breast conservation therapy: residual cancers after lumpectomy.保乳治疗中局部复发的预后因素:乳房肿瘤切除术后的残余癌
Surg Today. 1993;23(5):402-6. doi: 10.1007/BF00309497.